Gene · 6422
Papers4,318
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,318
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Placental network differences among obstetric syndromes identified with an integrated multiomics approach. | Commun Biol | 2025 | 40826226 | PubTator, text mining | PubMed |
| Experimental and numerical study on FRP-rehabilitated RC beam-column joints at high temperature with artificial neural network. | Sci Rep | 2025 | 40819120 | PubTator, text mining | PubMed |
| The fibrosis puzzle of systemic sclerosis-associated ILD and the quest for targeted interventions. | Ther Adv Respir Dis | 2025 | 40817801 | PubTator, text mining | PubMed |
| The role of m5C, m1A and m7G modifications in tumors of urinary system. | Front Cell Dev Biol | 2025 | 40809690 | PubTator, text mining | PubMed |
| Gut microbiota in gastric cancer: from pathogenesis to precision medicine. | Front Microbiol | 2025 | 40809053 | PubTator, text mining | PubMed |
| Bioinformatics-based prognostic value and in vitro functional validation of PTK6 in cutaneous melanoma. | Front Oncol | 2025 | 40809015 | PubTator, text mining | PubMed |
| Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression. | Nat Commun | 2025 | 40770193 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor 19 Disrupts Cartilage Development Via the FGFR4/β-catenin Axis. | Int J Biol Sci | 2025 | 40765829 | PubTator, text mining | PubMed |
| Integrated multiple machine learning and Mendelian randomization reveal LTF gene as a prognostic biomarker for nonspecific orbital inflammation. | BMC Pharmacol Toxicol | 2025 | 40760708 | PubTator, text mining | PubMed |
| CTHRC1 Derived From Cancer-Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF-STAT3 Pathway. | Cancer Med | 2025 | 40751418 | PubTator, text mining | PubMed |
| New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic. | Research (Wash D C) | 2025 | 40746825 | PubTator, text mining | PubMed |
| Multi-omics analysis of small extracellular vesicles in osteoarthritis: bridging the gap between molecular insights and clinical applications. | Burns Trauma | 2025 | 40740687 | PubTator, text mining | PubMed |
| Integrated network toxicology and bioinformatics reveal PFAS-driven prognostic biomarkers and molecular mechanisms in breast cancer: insights from transcriptome analysis and molecular docking. | Discov Oncol | 2025 | 40705188 | PubTator, text mining | PubMed |
| Chronic stress: a fourth etiology in tumorigenesis? | Mol Cancer | 2025 | 40676620 | PubTator, text mining | PubMed |
| Biomarker discovery for early breast cancer diagnosis using machine learning on transcriptomic data for biosensor development. | Comput Biol Med | 2025 | 40644891 | PubTator, text mining | PubMed |
| Identification of plasma proteins associated with seizures in epilepsy: A consensus machine learning approach. | PLoS One | 2025 | 40591616 | PubTator, text mining | PubMed |
| Epigenetics and Expression of the Wnt Signaling Pathway in Ulcerative Colitis. | Turk J Gastroenterol | 2025 | 40521787 | PubTator, text mining | PubMed |
| Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma. | Front Oncol | 2025 | 40492125 | PubTator, text mining | PubMed |
| Sohlh1 Modulates the Stemness and Differentiation of Glioma Stem-Like Cells by Inactivation of Wnt/β-Catenin Signalling Pathway via SFRP1. | J Cell Mol Med | 2025 | 40418209 | PubTator, text mining | PubMed |
| Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer. | Ann Med | 2025 | 40372974 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6422/papers?page=6